Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Baxter
Merck
Federal Trade Commission
Healthtrust
Citi

Generated: September 18, 2019

DrugPatentWatch Database Preview

APADAZ Drug Profile

  Try a free trial


See Plans and Pricing

« Back to Dashboard

When do Apadaz patents expire, and what generic alternatives are available?

Apadaz is a drug marketed by Kvk Tech Inc and is included in one NDA. There are five patents protecting this drug.

This drug has thirty-two patent family members in nineteen countries.

The generic ingredient in APADAZ is acetaminophen; benzhydrocodone hydrochloride. There are sixty-six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the acetaminophen; benzhydrocodone hydrochloride profile page.

Summary for APADAZ
International Patents:32
US Patents:5
Applicants:1
NDAs:1
Suppliers / Packagers: 2
Bulk Api Vendors: 1
Formulation / Manufacturing:see details
DailyMed Link:APADAZ at DailyMed
Drug patent expirations by year for APADAZ
Generic Entry Opportunity Date for APADAZ
Generic Entry Date for APADAZ*:
Constraining patent/regulatory exclusivity:
NDA:
Dosage:
TABLET;ORAL

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Synonyms for APADAZ
Acetaminophen / benzhydrocodone hydrochloride
Acetaminophen and benzhydrocodone hydrochloride
Acetaminophen mixture with benzhydrocodone hydrochloride
S900007390

US Patents and Regulatory Information for APADAZ

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Kvk Tech Inc APADAZ acetaminophen; benzhydrocodone hydrochloride TABLET;ORAL 208653-002 Jan 4, 2019 RX Yes No   Try a Free Trial   Try a Free Trial Y Y   Try a Free Trial
Kvk Tech Inc APADAZ acetaminophen; benzhydrocodone hydrochloride TABLET;ORAL 208653-001 Feb 23, 2018 RX Yes No   Try a Free Trial   Try a Free Trial Y   Try a Free Trial
Kvk Tech Inc APADAZ acetaminophen; benzhydrocodone hydrochloride TABLET;ORAL 208653-002 Jan 4, 2019 RX Yes No   Try a Free Trial   Try a Free Trial Y Y   Try a Free Trial
Kvk Tech Inc APADAZ acetaminophen; benzhydrocodone hydrochloride TABLET;ORAL 208653-003 Jan 4, 2019 RX Yes No   Try a Free Trial   Try a Free Trial Y Y   Try a Free Trial
Kvk Tech Inc APADAZ acetaminophen; benzhydrocodone hydrochloride TABLET;ORAL 208653-001 Feb 23, 2018 RX Yes No   Try a Free Trial   Try a Free Trial Y Y   Try a Free Trial
Kvk Tech Inc APADAZ acetaminophen; benzhydrocodone hydrochloride TABLET;ORAL 208653-003 Jan 4, 2019 RX Yes No   Try a Free Trial   Try a Free Trial Y   Try a Free Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Daiichi Sankyo
US Department of Justice
Healthtrust
Baxter
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.